InvesTrust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$667K Hold
1,716
– – 0.27% 78
2026
Q2
$664K Hold
1,716
– – 0.26% 79
2026
Q1
$502K Hold
1,716
– – 0.21% 79
2025
Q4
$602K Sell
1,716
-43
-2% -$14.5K 0.23% 79
2025
Q3
$568K Hold
1,759
– – 0.21% 78
2025
Q2
$684K Hold
1,759
– – 0.26% 73
2025
Q1
$765K Hold
1,759
– – 0.21% 69
2024
Q4
$649K Buy
+1,759
New +$736K 0.18% 71

Other funds holding ELV

InvesTrust's ELV Position: Q3 2026 in Review

InvesTrust held its Elevance Health (ELV) position steady in Q3 2026 at 1,716 shares worth $667K. The position accounts for 0.27% of the portfolio, ranked #78.

InvesTrust first reported a position in ELV in Q4 2024 and has held it in 8 quarters since. The position peaked at $765K in Q1 2025. 644 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • InvesTrust held 1,716 shares of Elevance Health worth $667K as of Q3 2026.
  • InvesTrust left its Elevance Health share count unchanged in Q3 2026.
  • Elevance Health made up 0.27% of InvesTrust's portfolio in Q3 2026, its #78 holding.
  • InvesTrust first reported a position in Elevance Health in Q4 2024 and has held it in 8 quarters since.
  • InvesTrust's Elevance Health position peaked at $765K in Q1 2025.
  • 644 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on InvesTrust's 13F filing for Q3 2026, filed 14 Oct 2026.